Skip to main content

Table 3 BPI scores at baseline, end of IR phase, and end of SR phase (ITT population)

From: A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer pain

Variable

Baseline* Mean (SD)

End of IR phase LS mean (SE)

End of SR phase LS mean (SE)

Worst pain

   

   Hydromorphone

6.3 (2.7)

5.0 (0.3)

3.5 (0.3)

   Morphine

6.2 (2.5)

4.8 (0.3)

4.3 (0.3)

Least pain

   

   Hydromorphone

2.7 (2.5)

1.8 (0.2)

1.8 (0.2)

   Morphine

2.9 (2.7)

2.2 (0.2)

1.8 (0.2)

Average pain

   

   Hydromorphone

5.0 (2.1)

3.6 (0.2)

3.4 (0.3)

   Morphine

5.1 (2.1)

3.6 (0.2)

3.2 (0.3)

Pain now AM

   

   Hydromorphone

4.0 (2.7)

3.3 (0.3)

2.4 (0.3)

   Morphine

4.1 (2.4)

3.4 (0.3)

2.8 (0.3)

Pain now PM

   

   Hydromorphone

4.8 (3.0)

3.6 (0.3)

2.6 (0.3)§

   Morphine

4.2 (2.5)

3.7 (0.3)

3.4 (0.3)

  1. Abbreviations: BPI, Brief Pain Inventory; CR, controlled-release; IR, immediate-release; LS, least-squares; SD, standard deviation; SE, standard error; SR, sustained-release
  2. *Hydromorphone, n = 99; morphine, n = 101
  3. †IR hydromorphone, n = 99; IR morphine, n = 101
  4. ‡OROS® hydromorphone, n = 77; CR morphine, n = 86
  5. §p = 0.0372 versus CR morphine